Chief Judge David R. Herndon of the Southern District of Illinois, the judge presiding over the federal Pradaxa litigation, has announced the plaintiffs’ leadership counsel who will oversee the interests of the plaintiffs in the Pradaxa litigation. TorHoerman Law is proud to announce that Tor Hoerman has been named as Co-Lead Counsel and Steven Davis has been named as Co-Liason Counsel. Tor and Steven look forward to cooperating with attorneys on both sides of the litigation in order to advance the litigation in a timely manner.
Chief Judge Herndon indicated that he anticipates trying the first case in approximately eighteen to twenty four months. Given the seriousness of the allegations and the impact this litigation can have on treaters that are currently prescribing Pradaxa, the plaintiffs’ leadership team is prepared to use their resources to advance the litigation efficiently.
As of today, about 125 cases are on file with the Southern District of Illinois. We anticipate those numbers will continue to rise.
Tor is proud to be named to leadership and looks forward to working with the following other exceptional attorneys, each of whom is also co-lead counsel:
- Roger Denton – Schlichter, Bogard & Denton
- Seth Katz – Burg Simpson
- Michael London – Douglas & London
- Mikal C. Watts – Watts, Guerra & Craft
In addition, the court has appointed an exceptionally highly qualified executive and steering committee, details of which can be found at the following link – Case Management Order Number 4, In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation